Pharmacopsychiatry 2018; 51(03): 82-88
DOI: 10.1055/s-0043-116855
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Prediction Model of Serum Lithium Concentrations

Kazunari Yoshida
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
,
Hiroyuki Uchida
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
2   Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada
,
Takefumi Suzuki
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
3   Department of Psychiatry, Inokashira Hospital, Tokyo, Japan
,
Masahiro Watanabe
4   School of Pharmacy, Syujitsu University, Okayama, Japan
,
Nariyasu Yoshino
5   School of Pharmacy, Nihon University, Chiba, Japan
,
Hitoshi Houchi
6   Department of Pharmacy, Kagawa University Hospital, Kagawa, Japan
,
Masaru Mimura
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
,
Noriyasu Fukuoka
5   School of Pharmacy, Nihon University, Chiba, Japan
› Author Affiliations
Further Information

Publication History

received 16 March 2017
revised 30 June 2017

accepted 13 July 2017

Publication Date:
02 August 2017 (online)

Zoom Image

Abstract

Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL).

Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects.

Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95% confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L.

Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.